Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 40, 2011 - Issue 1
Submit an article Journal homepage
841
Views
19
CrossRef citations to date
0
Altmetric
Articles

The number needed to treat for second-generation biologics when treating established rheumatoid arthritis: a systematic quantitative review of randomized controlled trials

LE Kristensen Department of Clinical Sciences, Lund, Section of Rheumatology, Lund University, SwedenCorrespondence[email protected]
,
AK Jakobsen Department of Clinical Sciences, Lund, Section of Rheumatology, Lund University, Sweden
,
EM Bartels The Parker Institute, Musculoskeletal Statistics Unit, Frederiksberg Hospital, Copenhagen University Hospital, Denmark
,
P Geborek Department of Clinical Sciences, Lund, Section of Rheumatology, Lund University, Sweden
,
H Bliddal The Parker Institute, Musculoskeletal Statistics Unit, Frederiksberg Hospital, Copenhagen University Hospital, Denmark; Centre for Sensory-Motor Interaction, Aalborg University, Aalborg, Denmark
,
T Saxne Department of Clinical Sciences, Lund, Section of Rheumatology, Lund University, Sweden
,
B Danneskiold-Samsøe The Parker Institute, Musculoskeletal Statistics Unit, Frederiksberg Hospital, Copenhagen University Hospital, Denmark; Centre for Sensory-Motor Interaction, Aalborg University, Aalborg, Denmark; Faculty of Health Science, University of Copenhagen, Denmark
&
R Christensen The Parker Institute, Musculoskeletal Statistics Unit, Frederiksberg Hospital, Copenhagen University Hospital, Denmark; Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, Denmark
 show all
Pages 1-7 | Accepted 05 May 2010, Published online: 15 Oct 2010

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Marie Fechtenbaum, Md Yuzaiful Md Yusof & Paul Emery. (2014) Certolizumab pegol in rheumatoid arthritis: current update. Expert Opinion on Biological Therapy 14:6, pages 841-850.
Read now
Y Hishitani, A Ogata, Y Shima, T Hirano, K Ebina, Y Kunugiza, K Shi, M Narazaki, K Hagihara, T Tomita, H Yoshikawa, T Tanaka & A Kumanogoh. (2013) Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis. Scandinavian Journal of Rheumatology 42:4, pages 253-259.
Read now
Sarah Horton, Ceara Walsh & Paul Emery. (2012) Certolizumab pegol for the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 12:2, pages 235-249.
Read now
Charalampos Papagoras & Alexandros A Drosos. (2011) Abatacept: a biologic immune modulator for rheumatoid arthritis. Expert Opinion on Biological Therapy 11:8, pages 1113-1129.
Read now

Articles from other publishers (15)

D Sean Riminton. (2023) Is immunology doing well? A look at 100 immune‐mediated inflammatory diseases for 100 years of the Journal. Immunology & Cell Biology 101:10, pages 896-901.
Crossref
Johanna Mucke, Hans-Uwe Simon & Gerd Rüdiger Burmester. (2022) The safety of antirheumatic drugs. Deutsches Ärzteblatt international.
Crossref
Victoria Charlton & Annette Rid. (2019) Innovation as a value in healthcare priority-setting: the UK experience. Social Justice Research 32:2, pages 208-238.
Crossref
Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Lara J Maxwell, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Maria E Suarez-Almazor, Peter Tugwell & George A Wells. (2017) Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2017:3.
Crossref
Tanja Schjødt Jørgensen, Carl Turesson, Meliha Kapetanovic, Martin Englund, Aleksandra Turkiewicz, Robin Christensen, Henning Bliddal, Pierre Geborek & Lars Erik Kristensen. (2017) EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry. PLOS ONE 12:2, pages e0169946.
Crossref
Anders Gülfe, Johan K. Wallman & Lars Erik Kristensen. (2016) EuroQol-5 dimensions utility gain according to British and Swedish preference sets in rheumatoid arthritis treated with abatacept, rituximab, tocilizumab, or tumour necrosis factor inhibitors: a prospective cohort study from southern Sweden. Arthritis Research & Therapy 18:1.
Crossref
Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Peter Tugwell & George A Wells. (2016) Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA). Cochrane Database of Systematic Reviews 2016:11.
Crossref
Lewis Carpenter, Elena Nikiphorou, Rachel Sharpe, Sam Norton, Kirsten Rennie, Frances Bunn, David L. Scott, Josh Dixey & Adam Young. (2016) Have radiographic progression rates in early rheumatoid arthritis changed? A systematic review and meta-analysis of long-term cohorts. Rheumatology 55:6, pages 1053-1065.
Crossref
Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Ahmed Kotb, Robin Christensen, Amy S Mudano, Lara J Maxwell, Nipam P Shah, Peter Tugwell & George A Wells. (2016) Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2016:5.
Crossref
Robin Christensen, Simon Tarp, Daniel E Furst, Lars E Kristensen & Henning Bliddal. (2013) Efficacy and safety of infliximab or adalimumab, versus abatacept, in patients with rheumatoid arthritis: ATTEST–AMPLE network randomized trial. International Journal of Clinical Rheumatology 8:6, pages 647-655.
Crossref
Licia Maria Henrique da Mota, Bóris Afonso Cruz, Claiton Viegas Brenol, Ivânio Alves Pereira, Lucila Stange Rezende-Fronza, Manoel Barros Bertolo, Max Vitor Carioca Freitas, Nilzio Antônio da Silva, Paulo Louzada-Junior, Rina Dalva Neubarth Giorgio, Rodrigo Aires Corrêa Lima, Wanderley Marques Bernardo & Geraldo da Rocha Castelar Pinheiro. (2013) Diretrizes para o tratamento da artrite reumatoide. Revista Brasileira de Reumatologia 53:2, pages 158-183.
Crossref
Licia Maria Henrique da Mota, Bóris Afonso Cruz, Claiton Viegas Brenol, Ivânio Alves Pereira, Lucila Stange Rezende-Fronza, Manoel Barros Bertolo, Max Vitor Carioca Freitas, Nilzio Antônio da Silva, Paulo Louzada-Junior, Rina Dalva Neubarth Giorgio, Rodrigo Aires Corrêa Lima, Wanderley Marques Bernardo & Geraldo da Rocha Castelar Pinheiro. (2013) Guidelines for the drug treatment of rheumatoid arthritis. Revista Brasileira de Reumatologia (English Edition) 53:2, pages 158-183.
Crossref
K. Albrecht, K. Krüger, U. Müller-Ladner & J. Wollenhaupt. (2012) Systematische Literaturrecherche für die S1-Leitlinie zur sequenziellen medikamentösen Therapie der rheumatoiden ArthritisSystematic literature research for S1 guidelines on sequential medical treatment of rheumatoid arthritis. Zeitschrift für Rheumatologie 71:7, pages 604-618.
Crossref
Sarah C Horton, Sudipto Das & Paul Emery. (2011) Certolizumab pegol in rheumatoid arthritis: a review of Phase III clinical trials and its role in real-life clinical practice. International Journal of Clinical Rheumatology 6:5, pages 517-527.
Crossref
S.C. Horton, C.A.E. Walsh & P. Emery. (2011) Established rheumatoid arthritis: Rationale for best practice – Physicians’ perspective of how to realise tight control in clinical practice. Best Practice & Research Clinical Rheumatology 25:4, pages 509-521.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.